Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track

T-cells and cancer cells

The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration. . . . → Read More: Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track

Biotech, Academic Labs Partner on Ultrasound Brain Therapy

Brain circuits

A developer of treatments for brain disorders and researchers at Stanford University aim to harness ultrasound to deliver drugs in nanoscale particles to precise regions of the brain. . . . → Read More: Biotech, Academic Labs Partner on Ultrasound Brain Therapy

Trial Okayed for Gene-Edited Stem Cell Lupus Treatment

Natural killer cell

A developer of treatments for cancer and autoimmune disorders from stem cells says FDA cleared its request to start a clinical trial of its therapy for systemic lupus erythematosus. . . . → Read More: Trial Okayed for Gene-Edited Stem Cell Lupus Treatment

Electric Pulses Induce Lung Cancer Immune Response

Lung cancer illustration

Results of a clinical trial show a lung cancer therapy using highly focused pulses with electrical energy show signs of immune responses that can treat the patients’ tumors. . . . → Read More: Electric Pulses Induce Lung Cancer Immune Response

Genetic Tests of Breast Cancer Patients Shown Useful

Breast cancer cell

Experiences from a rural hospital in North Carolina show hereditary genetic testing of all breast cancer patients is feasible and can result in changes in care for many patients. . . . → Read More: Genetic Tests of Breast Cancer Patients Shown Useful

Longevity Science Group Spins-Off Biotech Start-Up

Naked mole rat on black background

An organization funding research on extending the human life span by preventing age-related diseases is founding its first biotechnology company. . . . → Read More: Longevity Science Group Spins-Off Biotech Start-Up

Collapsed Microbiome Biotech Sells Off Assets

Microbiome illustration

A developer of therapies addressing the body’s microbe communities is selling off key assets to another biotechnology company, after problems developed with its lead program. . . . → Read More: Collapsed Microbiome Biotech Sells Off Assets

Industry-Academic Center to Boost Rare Disease Therapies

Network pointer

An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K. . . . → Read More: Industry-Academic Center to Boost Rare Disease Therapies

FDA Clears Genetic Cancer Risk Detection Test

DNA illustration

The Food and Drug Administration authorized marketing of a genetic test for detecting hundreds of gene variants associated with a higher risk of developing certain cancers. . . . → Read More: FDA Clears Genetic Cancer Risk Detection Test

A.I. Mammogram Screening Shown to Improve Cancer Detection

Mammogram

Results of a clinical trial show one radiologist using software with artificial intelligence can detect more breast cancer cases in mammograms than current reviews by two radiologists. . . . → Read More: A.I. Mammogram Screening Shown to Improve Cancer Detection